• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA:动脉粥样硬化性卒中基因诊断和治疗的潜在靶点。

MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke.

机构信息

Department of Neurology, Hubei University of Medicine, Shiyan City, Hubei Province, China.

Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, China.

出版信息

Int J Neurosci. 2021 Mar;131(3):283-288. doi: 10.1080/00207454.2020.1738428. Epub 2020 Mar 31.

DOI:10.1080/00207454.2020.1738428
PMID:32129115
Abstract

Stroke is one of the major diseases that endanger the physical health life of middle-aged and old people. It has the characteristics of high incidence, mortality and disability rate. Atherosclerosis is the main intervention target for stroke prevention and treatment. MiRNAs are highly expressed in the cerebral vasculature and play an important regulatory role in the pathogenesis of neuronal damage and ischemic stroke. This article reviews the mechanism of action between miRNAs and atherosclerosis, stroke, ischemia-reperfusion injury, collateral circulation and circRNA molecular networks, providing theoretical support for miRNA in gene diagnosis and drug therapy of atherosclerotic stroke.

摘要

中风是危害中老年人身体健康生命的主要疾病之一,具有发病率、死亡率和致残率高的特点。动脉粥样硬化是中风预防和治疗的主要干预靶点。miRNAs 在脑血管中高度表达,在神经元损伤和缺血性中风的发病机制中发挥重要的调节作用。本文综述了 miRNAs 与动脉粥样硬化、中风、缺血再灌注损伤、侧支循环和 circRNA 分子网络之间的作用机制,为 miRNA 在动脉粥样硬化性中风的基因诊断和药物治疗方面提供了理论支持。

相似文献

1
MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke.miRNA:动脉粥样硬化性卒中基因诊断和治疗的潜在靶点。
Int J Neurosci. 2021 Mar;131(3):283-288. doi: 10.1080/00207454.2020.1738428. Epub 2020 Mar 31.
2
Bioinformatic Analysis of Potential microRNAs in Ischemic Stroke.缺血性中风中潜在微小RNA的生物信息学分析
J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1753-1759. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.023. Epub 2016 Apr 14.
3
microRNAs: innovative targets for cerebral ischemia and stroke.微小 RNA :脑缺血和脑卒中的创新靶点。
Curr Drug Targets. 2013 Jan 1;14(1):90-101. doi: 10.2174/138945013804806424.
4
Identification of Circular RNA hsa_circ_0001599 as a Novel Biomarker for Large-Artery Atherosclerotic Stroke.环状 RNA hsa_circ_0001599 作为大动脉粥样硬化性脑卒中新型生物标志物的鉴定。
DNA Cell Biol. 2021 Mar;40(3):457-468. doi: 10.1089/dna.2020.5662. Epub 2021 Jan 25.
5
Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke.侧支血流对急性缺血性卒中血管内治疗患者的影响。
Stroke. 2014 Apr;45(4):1035-9. doi: 10.1161/STROKEAHA.113.004085. Epub 2014 Feb 25.
6
Plasma Levels of miR-125b-5p and miR-206 in Acute Ischemic Stroke Patients After Recanalization Treatment: A Prospective Observational Study.再通治疗后急性缺血性脑卒中患者血浆中miR-125b-5p和miR-206的水平:一项前瞻性观察研究
J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1654-1661. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.026. Epub 2019 Mar 14.
7
Identification of novel biomarkers in ischemic stroke: a genome-wide integrated analysis.缺血性脑卒中新型生物标志物的鉴定:全基因组综合分析。
BMC Med Genet. 2020 Mar 30;21(1):66. doi: 10.1186/s12881-020-00994-3.
8
MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke.微小 RNA:在缺血性脑卒中的预测、诊断、预后和治疗策略中的新进展。
Cell Mol Neurobiol. 2022 Jul;42(5):1301-1319. doi: 10.1007/s10571-020-01028-5. Epub 2020 Dec 24.
9
Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies.缺血性卒中的侧支循环:评估工具与治疗策略
Stroke. 2015 Nov;46(11):3302-9. doi: 10.1161/STROKEAHA.115.010508. Epub 2015 Oct 8.
10
Early Collateral Recruitment After Stroke in Infants and Adults.婴幼儿和成人卒中后的早期侧支循环募集
Stroke. 2019 Sep;50(9):2604-2611. doi: 10.1161/STROKEAHA.119.025353. Epub 2019 Jul 24.

引用本文的文献

1
Correlation of MicroRNA-125b, Sirtuin, and Signal Transducer and Activator of Transcription 3 with Biochemical Parameters and Risk Factors in Atherosclerosis Patients.微小RNA-125b、沉默调节蛋白和信号转导与转录激活因子3与动脉粥样硬化患者生化参数及危险因素的相关性
Rep Biochem Mol Biol. 2024 Jan;12(4):631-642. doi: 10.61186/rbmb.12.4.631.
2
DAE-CFR: detecting microRNA-disease associations using deep autoencoder and combined feature representation.DAE-CFR:使用深度自动编码器和组合特征表示来检测 microRNA-疾病关联。
BMC Bioinformatics. 2024 Mar 29;25(1):139. doi: 10.1186/s12859-024-05757-y.
3
Identification and characterization of extrachromosomal circular DNA in large-artery atherosclerotic stroke.
鉴定和描述大动脉粥样硬化性卒中患者的染色体外环状 DNA。
J Cell Mol Med. 2024 Apr;28(7):e18210. doi: 10.1111/jcmm.18210.
4
The phosphokinase activity of IRE1ɑ prevents the oxidative stress injury through miR-25/Nox4 pathway after ICH.脑出血后,IRE1ɑ的磷酸激酶活性通过miR-25/Nox4途径预防氧化应激损伤。
CNS Neurosci Ther. 2024 Apr;30(4):e14537. doi: 10.1111/cns.14537. Epub 2023 Nov 23.
5
Interfering microRNA-410 attenuates atherosclerosis via the HDAC1/KLF5/IKBα/NF-κB axis.干扰性微小RNA-410通过HDAC1/KLF5/IKBα/NF-κB轴减轻动脉粥样硬化。
Mol Ther Nucleic Acids. 2021 Mar 13;24:646-657. doi: 10.1016/j.omtn.2021.03.009. eCollection 2021 Jun 4.
6
Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203.长链非编码 RNA OIP5-AS1 通过靶向 miR-203 促进鼻咽癌的疾病进展。
Biomed Res Int. 2021 Feb 5;2021:9850928. doi: 10.1155/2021/9850928. eCollection 2021.